£1.5M
The oversubscribed raise was led by investment platform Wealth Club alongside existing backers Deepbridge Capital and Boundary Capital.
G
Glyconics
Glyconics builds rapid non-invasive diagnostic tools for point-of-care health screening.
£1.5MTotal raised
Glyconics is a medtech company developing non-invasive point-of-care diagnostic tools using infrared spectrometry. The firm is focused on creating rapid screening solutions for conditions such as diabetes.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Glyconics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Päivi Paldánius
Chief Medical Officer
Päivi serves as Chief Medical Officer at Glyconics and a Senior Clinical Scientist at the University of Helsinki. Her background includes medical leadership roles in diabetes and hypertension at Novartis.
LinkedInKP
Kam Pooni
CEO
Kam brings life sciences and diagnostics experience from roles including chief product officer at PrecisionLife and chief executive of Glyconics. He also holds non-executive positions at the University of Southampton Science Park.
LinkedIn